
Executive Editor, Endpoints News (@endpts). Got a confidential tip? Message me on Signal: DrewArmstrong.39
NYC
Joined October 2009
- Tweets10.1K
- Following3.1K
- Followers28.9K
- Likes10.8K
Drew Armstrong retweeted
a good argument for why spokespeople should be pushed to put their names on company statements
teapaw.org/ShakeelHashim/status/2…
Drew Armstrong retweeted
Next time you think that short sellers just make shit up - have a look at this SIX MONTH OLD tweet - which basically alleges the affair that is now news.
Replying to @CulperResearch
9) $NVDA CEO Huang has walked alongside Megaspeed at every step, and seems to have a close relationship with Megaspeed's Alice Huang. They partied together in June 2024 - same month as the Apex/Alibaba pledge, then dined together in May 2025 - just after U.S. trade restrictions.
Drew Armstrong retweeted
The FDA says its is looking into a “serious risk” of cancer linked to Novartis’ spinal muscular atrophy gene therapy Zolgensma, following 7 new cases: endpoints.news/fda-launches-…
IT'S A LITTLE HOT OUT THERE
“I’ve never seen anything like it,” Church told me, saying that he believed it violated the spirit of scientific collaboration. “It’s the kind of cutthroat mentality that you see in Hollywood.”
Some Friday night drama in my latest for @endpts: endpoints.news/church-quits-…
1
10
3,671
Drew Armstrong retweeted
“I’ve never seen anything like it,” Church told me, saying that he believed it violated the spirit of scientific collaboration. “It’s the kind of cutthroat mentality that you see in Hollywood.”
Some Friday night drama in my latest for @endpts: endpoints.news/church-quits-…
Drew Armstrong retweeted
We're reporting only a fraction of measles cases in the US; some estimates put it as low as 20% in states like PA. This outbreak is much larger than what's reported and is spilling into highly vulnerable communities like babies and pregnant women. We will lose our Measles elimination status this month, and it will take years of responsible public health management to get it back.
bloomberg.com/news/articles/…
Drew Armstrong retweeted
Tips, scoops, and exclus can officially be sent to [email protected]! 👀 Add me to your press lists too
💊🚨 Big news! I am so thrilled to be joining @endpts to report on the FDA starting Nov. 9.
I want all your tips, scoops, exclusives and intros to people I should know in the FDA and pharma policy world. New email address coming soon!
Great feature read from @ky_lahucik about long-neglected preeclampsia and the early efforts to find treatments:
endpoints.news/preeclampsia-…
Drew Armstrong retweeted
The US midterm elections and biopharma teapaw.org/i/broadcasts/2gqWlyAWQ…
Firing up in a few mins! See you soon!
🎙️Today at 130pm -- we're talking midterms and biopharma! What the US midterm vote means for:
💵MFN/Drug pricing
🇨🇳China policy
📢Drug CEOs getting hauled to DC
📨Subpeona-rama
Will @maxonwifi + @NickShipley1 -- see you there!
youtube.com/live/ghjQxZj1bWQ…
3
981
I'm operating on 2 hours of sleep, three coffees, halloween candy and TAKES. Should be lit.
lnkd.in/p/gRkajWpF
7
935
Drew Armstrong retweeted
🎙️ Live today at 1:30 pm ET: @ArmstrongDrew, @maxonwifi and Nick Shipley unpack what the midterms mean for drug pricing, MFN deals and the FDA. endpoints.news/post-hoc-live…
Healthcare's AOL-Time Warner deal
Drew Armstrong retweeted
there will be levels of yapping tomorrow the likes of which have never been seen before
🎙️ Live tomorrow at 1:30 pm ET: What the midterms mean for biopharma, with @ArmstrongDrew, @maxonwifi and policy expert Nick Shipley. endpoints.news/post-hoc-live…
🎙️Today at 130pm -- we're talking midterms and biopharma! What the US midterm vote means for:
💵MFN/Drug pricing
🇨🇳China policy
📢Drug CEOs getting hauled to DC
📨Subpeona-rama
Will @maxonwifi + @NickShipley1 -- see you there!
youtube.com/live/ghjQxZj1bWQ…
🎙️Tomorrow at 1:30pm ET, we'll be talking about what the midterms mean for biotech and pharma! 🗳️🧬
Join me, @maxonwifi + friend of the show / guest @NickShipley1 to unpack what happens if the Dems take control of one or both houses of Congress.
endpoints.news/post-hoc-live…
Drew Armstrong retweeted
Pre-revenue biotechs are among the businesses most eagerly backing an SEC proposal to cut in half the number of financial reports required each year.
But whether most biotechs would move to semiannual filing if given the choice is an open question. news.bloomberglaw.com/financ…
We got another great one! Welcome, @mayagoldman_ !
💊🚨 Big news! I am so thrilled to be joining @endpts to report on the FDA starting Nov. 9.
I want all your tips, scoops, exclusives and intros to people I should know in the FDA and pharma policy world. New email address coming soon!




















